Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2022
Illumina files trade-secrets lawsuit against Guardant Health
Illumina filed a lawsuit against Guardant Health, alleging that Guardant's co-founders took confidential Illumina documents and that patents central to Guardant's cancer-detection work relied on that information. Guardant disputed Illumina's claims and said they had no merit.
2021
Guardant Health sues Natera over alleged advertising claims
Guardant Health sued Natera, alleging that Natera ran a campaign of false and misleading advertising concerning Guardant's Reveal cancer assay and made unfounded comparisons with its own product. These are allegations in the lawsuit.
2020
FDA approves Guardant360 CDx for EGFR mutation identification
The FDA approved Guardant360 CDx to identify EGFR mutations in patients with metastatic non-small cell lung cancer; the approval applies to this use, according to the article.